Zimmer Biomet Holdings Inc (ZBH) gains 2.53% for July 21

Equities Staff  |

Zimmer Biomet Holdings Inc (NYSE: ZBH) shares gained 2.53%, or $3.94 per share, to close Wednesday at $159.57. After opening the day at $157.52, shares of Zimmer Biomet fluctuated between $159.84 and $156.29. 1,753,774 shares traded hands an increase from their 30 day average of 1,269,497. Wednesday's activity brought Zimmer Biomet’s market cap to $33,267,488,857.

Zimmer Biomet is headquartered in Warsaw, Indiana..

About Zimmer Biomet Holdings Inc

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

Visit Zimmer Biomet Holdings Inc’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Zimmer Biomet Holdings Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Zimmer Biomet Holdings Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content